Miranda-Filho A, Piñeros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5(1):e14–24.

Article  PubMed  Google Scholar 

Mueller KT, Waldron E, Grupp SA, Levine JE, Laetsch TW, Pulsipher MA, et al. Clinical pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia. Clin cancer Research: Official J Am Association Cancer Res. 2018;24(24):6175–84.

Article  CAS  Google Scholar 

O’Connor D, Bate J, Wade R, Clack R, Dhir S, Hough R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056–61.

Article  PubMed  Google Scholar 

Vrooman LM, Silverman LB. Treatment of Childhood Acute Lymphoblastic Leukemia: prognostic factors and clinical advances. Curr Hematol Malig Rep. 2016;11(5):385–94.

Article  PubMed  Google Scholar 

Lynch SV, Pedersen O. The human intestinal microbiome in Health and Disease. N Engl J Med. 2016;375(24):2369–79.

Article  CAS  PubMed  Google Scholar 

Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76(3):473–93.

Article  CAS  PubMed  Google Scholar 

Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet (London England). 2020;395(10230):1146–62.

Article  CAS  PubMed  Google Scholar 

Peppas I, Ford AM, Furness CL, Greaves MF. Gut microbiome immaturity and childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2023;23(8):565–76.

Article  CAS  PubMed  Google Scholar 

De Pietri S, Ingham AC, Frandsen TL, Rathe M, Krych L, Castro-Mejía JL, et al. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: the impact of the gut microbiota. Int J Cancer. 2020;147(7):1953–62.

Article  PubMed  Google Scholar 

Qiu K, Liao X, Li Y, Huang K, Xu H, Fang J et al. Real-world presentation and prognostic effect of allogeneic blood transfusion during the intensive induction phase in Pediatric Acute Lymphoblastic Leukemia. Cancers. 2023;15(18).

Chua LL, Rajasuriar R, Lim YAL, Woo YL, Loke P, Ariffin H. Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy. BMC Cancer. 2020;20(1):151.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinf (Oxford England). 2014;30(15):2114–20.

CAS  Google Scholar 

Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F, Maharjan S et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife. 2021;10.

Caspi R, Billington R, Fulcher CA, Keseler IM, Kothari A, Krummenacker M, et al. The MetaCyc database of metabolic pathways and enzymes. Nucleic Acids Res. 2018;46(D1):D633–9.

Article  CAS  PubMed  Google Scholar 

Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.

Article  PubMed  PubMed Central  Google Scholar 

Sági V, Makra N, Csoszánszki N, Decmann A, Szabó D, Garami M. The influence of the gut Microbiome in Paediatric Cancer Origin and Treatment. Antibiot (Basel Switzerland). 2022;11(11).

Zhou Y, Zhou C, Zhang A. Gut microbiota in acute leukemia: current evidence and future directions. Front Microbiol. 2022;13:1045497.

Article  PubMed  PubMed Central  Google Scholar 

Montassier E, Gastinne T, Vangay P, Al-Ghalith GA, Bruley des Varannes S, Massart S, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42(5):515–28.

Article  CAS  PubMed  Google Scholar 

Huang Y, Yang W, Liu H, Duan J, Zhang Y, Liu M, et al. Effect of high-dose methotrexate chemotherapy on intestinal bifidobacteria, Lactobacillus and Escherichia coli in children with acute lymphoblastic leukemia. Experimental Biology Med (Maywood NJ). 2012;237(3):305–11.

Article  CAS  Google Scholar 

Thomas R, Wong WSW, Saadon R, Vilboux T, Deeken J, Niederhuber J, et al. Gut microbial composition difference between pediatric ALL survivors and siblings. Pediatr Hematol Oncol. 2020;37(6):475–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhuta R, DeNardo B, Wang J, Atoyan J, Zhang Y, Nelson D, et al. Durable changes in the gut microbiome in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2021;68(12):e29308.

Article  CAS  PubMed  Google Scholar 

Chua LL, Rajasuriar R, Azanan MS, Abdullah NK, Tang MS, Lee SC, et al. Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. Microbiome. 2017;5(1):35.

Article  PubMed  PubMed Central  Google Scholar 

Tandon D, Haque MM, Gote M, Jain M, Bhaduri A, Dubey AK, et al. A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora. Sci Rep. 2019;9(1):5473.

Article  PubMed  PubMed Central  Google Scholar 

Gao X, Miao R, Zhu Y, Lin C, Yang X, Jia R, et al. A new insight into acute lymphoblastic leukemia in children: influences of changed intestinal microfloras. BMC Pediatr. 2020;20(1):290.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nyhlén A, Ljungberg B, Nilsson-Ehle I, Nord CE. Impact of combinations of antineoplastic drugs on intestinal microflora in 9 patients with leukaemia. Scand J Infect Dis. 2002;34(1):17–21.

Article  PubMed  Google Scholar 

Rajagopala SV, Yooseph S, Harkins DM, Moncera KJ, Zabokrtsky KB, Torralba MG, et al. Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis. BMC Genomics. 2016;17(1):635.

Article  PubMed  PubMed Central  Google Scholar 

Hakim H, Dallas R, Wolf J, Tang L, Schultz-Cherry S, Darling V, et al. Gut Microbiome Composition predicts infection risk during Chemotherapy in Children with Acute Lymphoblastic Leukemia. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2018;67(4):541–8.

Article  CAS  Google Scholar 

Shen Z, Gu X, Cao H, Mao W, Yang L, He M, et al. Characterization of microbiota in acute leukemia patients following successful remission induction chemotherapy without antimicrobial prophylaxis. Int Microbiology: Official J Span Soc Microbiol. 2021;24(2):263–73.

Article  CAS  Google Scholar 

Nearing JT, Connors J, Whitehouse S, Van Limbergen J, Macdonald T, Kulkarni K, et al. Infectious complications are Associated with alterations in the gut Microbiome in Pediatric patients with Acute Lymphoblastic Leukemia. Front Cell Infect Microbiol. 2019;9:28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105(11):2524–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496–503.

Article  CAS  PubMed  Google Scholar 

Litvak Y, Byndloss MX, Tsolis RM, Bäumler AJ. Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction. Curr Opin Microbiol. 2017;39:1–6.

Article  CAS  PubMed  Google Scholar